Pyrimethamine

• UNSPSC Description:

  Pyrimethamine (Pirimecidan) is a potent, orally active dihydrofolate reductase (DHFR) inhibitor. Pyrimethamine is an antimalarial agent. Pyrimethamine affects the nucleoprotein metabolism of malarial parasites by interference in the folic–folinic acid systems and affects cell division by inhibiting the conversion of dihydrofolate to tetrahydrofolate[1][2].

• Target Antigen:

  Antifolate; Parasite

• Type:

  Reference compound

• Related Pathways:

  Anti-infection;Cell Cycle/DNA Damage

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/pyrimethamine.html

• Solubility:

  DMSO : 20 mg/mL (ultrasonic)

• Smiles:

  NC1=NC(N)=C(C2=CC=C(Cl)C=C2)C(CC)=N1

• Molecular Weight:

  248.71

• References & Citations:

  [1]Aikawa M, et, al. Studies on nuclear division of a malarial parasite under pyrimethamine treatment. J Cell Biol. 1968 Dec;39(3):749-54.|[2]Martins-Duarte ÉS, et, al. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model. Exp Parasitol. 2013 Mar;133(3):294-9.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  Launched

• CAS Number:

  58-14-0